Podcasts about mucinous

Dr. Rick Greene discusses with Dr. Brett Ecker the association between extent of resection and disease-specific survival  in mucinous and non-mucinous appendiceal adenocarcinomas as reported in his article, "Extent of Resection and Long-Term Outcomes for Appendiceal Adenocarcinoma: a SEER Database Analysis of Mucinous and non-Mucinous Histologies.” https://doi.org/10.1245/s10434-024-15233-9

Ripped from the pages of the popular Wildfire Magazine anthology, “Igniting the Fire Within,” we've curated this special mini podcast for you. Each Friday, hear a new bite-sized episode. Featuring “just the stories” from the book read by the authors. Think of this as your dynamic audiobook version of Igniting the Fire Within. Enjoy! This episode features Julie Stonefelt reading her essay “After Death Leaves Its Calling Card.” Julie Stonefelt. Park Ranger and Co-Founder of Wild Homestead Living. Diagnosed at 35. DCIS and Mucinous carcinoma, ER+. Snoqualmie Valley, WA. Buy the Wildfire book “Igniting the Fire Within: Stories of Healing, Hope & Humor, Inside Today's Young Breast Cancer Community”: https://www.amazon.com/dp/B0BJVJ629F?ref_=pe_3052080_397514860More about Julie: https://www.instagram.com/wildhomesteadliving/Hear Julie's story followed by a conversation with April Stearns on The Burn: https://player.captivate.fm/episode/1f857507-e12f-4c6c-a410-2e1da06499cbGet the free Wildfire email newsletter: https://www.wildfirecommunity.orgLearn about Wildfire writing workshops: https://www.wildfirecommunity.org/workshopsShop Wildfire merch & more: https://www.wildfirecommunity.org/shopSend your voice recording testimonial to editor@wildfirecommunity.org*Free* Get Wildfire and The Burn freebies here: https://www.wildfirecommunity.org/free

Full article: https://www.ajronline.org/doi/abs/10.2214/AJR.23.29002  Mohanned Alnammi, MD discusses a study that assessed the frequency of mucinous degeneration following neoadjuvant therapy and to compare outcomes among patients with nonmucinous, mucinous tumors, and those with mucinous degeneration on MRI. It revealed that mucinous degeneration is relatively uncommon and did not have a clear association with cancer recurrence or patient survival. The study emphasized the limitations of MRI in differentiating between cellular and acellular mucin and indicated a need for more advanced imaging techniques.

Join the Behind the Knife HPB team as we dive deeper into the complex world of IPMNs with a journal article review of a recent JAMA Surgery publication and the first author of the article! Learning Objectives: In this episode, we discuss the article, “Progression vs Cyst Stability of Branch-Duct Intraductal Papillary Mucinous Neoplasms After Observation and Surgery.”  This article describes a multicenter retrospective study of centers in Italy, Korea, Singapore, and the US that specifically assessed what dynamic variables are associated with malignant progression in pathologically proven IMPNs under at least a year of initial surveillance.  Hosts: Timothy Vreeland, MD, FACS (@vreelant) is an Assistant Professor of Surgery at the Uniformed Services University of the Health Sciences and Surgical Oncologist at Brooke Army Medical Center Daniel Nelson, DO, FACS (@DWNelsonHPB) is an Associate Professor of Surgery at the Uniformed Services University of the Health Sciences and Surgical Oncologist at William Beaumont Army Medical Center Connor Chick, MD (@connor_chick) is a PGY-6 General Surgery resident at Brooke Army Medical Center Lexy (Alexandra) Adams, MD, MPH (@lexyadams16) is a PGY-5 General Surgery resident at Brooke Army Medical Center Beth Carpenter, MD (@elizcarpenter16) is a PGY-4 General Surgery resident at Brooke Army Medical Center Guest:  Dr. Giovanni Marchegiani is a pancreas surgeon within the department of general and pancreatic surgery at the University of Verona in Italy.  His research interests include exocrine and cystic neoplasms of the pancreas.  He is the first author of the study discussed in the episode in addition to over 100 additional scientific, peer-reviewed articles. Journal Article: 1.     Marchegiani G, Pollini T, Andrianello S, et al. Progression vs Cyst Stability of Branch-Duct Intraductal Papillary Mucinous Neoplasms After Observation and Surgery. JAMA Surg. 2021;156(7):654–661. doi:10.1001/jamasurg.2021.1802 Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out other HPB episodes here: https://behindtheknife.org/podcast-category/hepatobiliary/

Full article: https://www.ajronline.org/doi/10.2214/AJR.22.28139  Wenhui Zhou, MD, PhD reviews a recent AJR article which developed and validated a nomogram combining clinical and CT-based radiomics features to differentiate pneumonia-type IMA and pneumonia. This nomogram outperformed radiologist interpretation or clinical factors alone, representing a useful tool in this difficult-to-diagnose disease.

What's the one clinical scenario where you can really save a patient's life with a pancreatectomy? An IPMN with high-grade dysplasia! Join the Behind the Knife HPB Team for a deep dive into the complex decision-making surgical management of IPMNs. Learning Objectives In this episode, we review the basics of intraductal papillary mucinous neoplasms, how to evaluate patients with a cystic mass of the pancreas, guidelines for surveillance, and indications for resection. We discuss key concepts such as Worrisome Features and High-Risk Stigmata and how those influence surgical decision-making, and tackle a few of the most challenging scenarios surgeons may face when treating patients with IPMNs.   Hosts: Timothy Vreelant, MD, FACS (@vreelant) is an Assistant Professor of Surgery at the Uniformed Services University of the Health Sciences and Surgical Oncologist at Brooke Army Medical Center Daniel Nelson, DO, FACS (@usarmydoc24) is an Associate Professor of Surgery at the Uniformed Services University of the Health Sciences and Surgical Oncologist at William Beaumont Army Medical Center Connor Chick, MD (@connor_chick) is a PGY-6 General Surgery resident at Brooke Army Medical Center Lexy (Alexandra) Adams, MD, MPH (@lexyadams16) is a PGY-5 General Surgery resident at Brooke Army Medical Center Beth Carpenter, MD (@elizcarpenter16) is a PGY-4 General Surgery resident at Brooke Army Medical Center Links to Papers Referenced in this Episode Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas Pancreatology. 2017 Sep-Oct;17(5):738-753. https://pubmed.ncbi.nlm.nih.gov/28735806/ Number of Worrisome Features and Risk of Malignancy in Intraductal Papillary Mucinous Neoplasm.  J Am Coll Surg. 2022 Jun 1;234(6):1021-1030.  https://pubmed.ncbi.nlm.nih.gov/35703792/ Extent of Surgery and Implications of Transection Margin Status after Resection of IPMNs.  Gastroenterology Research and Practice 2014, 1–10. https://pubmed.ncbi.nlm.nih.gov/25276122/ Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out other Hepatobiliary Surgery episodes here: https://behindtheknife.org/podcast-category/hepatobiliary/

In this radiology lecture, we reveal the imaging appearance of mucinous cystadenocarcinoma of the ovary and explain differentiating features from The post Case of the Week: Ovarian Mucinous Cystadenocarcinoma (Ultrasound & MRI) appeared first on Radiologist Headquarters.

10/11/2021 | Mucinous Cystic Neoplasm of the Pancreas: CT Appearance with Key Imaging Features - Part 2

10/04/2021 | Mucinous Cystic Neoplasm of the Pancreas: CT Appearance with Key Imaging Features - Part 1

Part 5 of this 9 part series on Ovarian Cysts. A GOOPEY ovarian cyst ; ) --- Send in a voice message: https://anchor.fm/dr-mcdaniel/message

11/09/2020 | Mucinous Cystic Neoplasm (MCN) of the Pancreas: What You Need to Know - Part 2

11/02/2020 | Mucinous Cystic Neoplasm (MCN) of the Pancreas: What You Need to Know - Part 1

Carrie Ann teaches Maturation to elementary and middle school kids. Her passion is to help everyone love and accept their unique individual body and for Carrie Anne this starts with teaching our youth that puberty is not to be feared but to be embraced. 0:00:00 How the cancer was discovered0:08:35 Port-a cath0:15:28 Six weeks to live0:22:00 Telling her children0:30:10 A gift of awareness0:35:15 Uterus, ovaries, cervix & breasts removed0:42:35 Self-love0:46:04 Navigating chemotherapy0:51:47 Still alive at Christmas0:57:35 Cancer-versary1:07:15 Radiation1:12:20 Masculinity1:17:00 Cancer as a curriculum1:33:45 Mentors1:38:29 Living freely with cancer1:49:50 The support of others1:53:51 Dating after cancer2:08:45 Funeral and wake considerations2:14:15 Being the observer of our own thinking2:19:39 Living in gratitude - recorded 2/28/2020

Mucinous Ovarian Cancer is a rare type of ovarian cancer. Shea and I discuss the process of getting diagnosed with this rare cancer. We explore the challenges of figuring out a treatment plan, especially with a rare cancer. We discuss the importance and difficulties in getting second opinions. We also discuss the unique problems with ovarian cancer such as saving eggs and preparations for future parenthood. --- Support this podcast: https://podcasters.spotify.com/pod/show/rick-hyman/support

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Katherine Kurnit to discuss GI-based chemotherapy in ovarian mucinous cancers. Dr. Kurnit is an Assistant Professor at the University of Chicago in the section of Gynecologic Oncology. Her research interests include developmental therapeutics and early phase clinical trials for women with gynecologic malignancies.

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. James Wright from Colubia University College of Physicians and Surgeons to talk about postoperative therapy in stage IC mucinous tumors.

Bronchioloalveolar carcinoma (BAC) is an unusual subtype of lung cancer; medical oncologist Dr. Jack West reviews the evidence on the best systemic therapy to treat advanced, multifocal BAC.

Bronchioloalveolar carcinoma (BAC) is an unusual subtype of lung cancer; medical oncologist Dr. Jack West reviews the evidence on the best systemic therapy to treat advanced, multifocal BAC.

Bronchioloalveolar carcinoma (BAC) is an unusual subtype of lung cancer; medical oncologist Dr. Jack West reviews the evidence on the best systemic therapy to treat advanced, multifocal BAC.

Unfortunately, there is as much misinformation as good information about the unusual subtupe of lung cancer known as bronchioloalveolar carcinoma (BAC) or adenocarcinoma in situ. Dr. Jack West reviews the top 5 myths.

Unfortunately, there is as much misinformation as good information about the unusual subtupe of lung cancer known as bronchioloalveolar carcinoma (BAC) or adenocarcinoma in situ. Dr. Jack West reviews the top 5 myths.

Unfortunately, there is as much misinformation as good information about the unusual subtupe of lung cancer known as bronchioloalveolar carcinoma (BAC) or adenocarcinoma in situ. Dr. Jack West reviews the top 5 myths.

Bronchioloalveolar carcinoma (BAC), also known as adenocarcinoma in situ, is an unusual subtype of lung cancer with its own appearance under a microscope and on imaging. Dr. Jack West introduces some of the basics of the unique features of BAC.

Bronchioloalveolar carcinoma (BAC), also known as adenocarcinoma in situ, is an unusual subtype of lung cancer with its own appearance under a microscope and on imaging. Dr. Jack West introduces some of the basics of the unique features of BAC.

Bronchioloalveolar carcinoma (BAC), also known as adenocarcinoma in situ, is an unusual subtype of lung cancer with its own appearance under a microscope and on imaging. Dr. Jack West introduces some of the basics of the unique features of BAC.

This slide presentation by medical oncologist and lung cancer expert Dr. Jack West describes the development of current standards and anticipated benefits vs. risks of second line chemotherapy for advanced non-small cell lung cancer (NSCLC).

This slide presentation by medical oncologist and lung cancer expert Dr. Jack West describes the unique clinical, imaging, and treatment response features of advanced bronchioloalveolar carcinoma (BAC), a distinct sybtype of lung adenocarcinoma.